The role of the second and third extracellular loops of the adenosine A1 receptor in activation and allosteric modulation.

The adenosine A1 receptor is a member of the large membrane protein family that signals through G proteins, the G protein-coupled receptors (GPCRs). GPCRs consist of seven transmembrane domains connected by three intracellular and three extracellular loops. Their N-terminus is extracellular, the C-terminal tail is in the cytoplasm. The transmembrane domains in receptor subfamilies that bind the same endogenous ligand, such as dopamine or adenosine, tend to be highly similar. In contrast, the loop regions can vary greatly, both in sequence and in length, and the role these loops have in the activation mechanism of the receptors remains unclear. Here, we investigated the activating role of the second and third extracellular loop of the human adenosine A1 receptor. By means of an (Ala)3 mutagenic scan in which consecutive sets of three amino acids were mutated into alanine residues in EL2 and a classical alanine scan in EL3, we revealed a strong regulatory role for the second extracellular loop (EL2) of the human adenosine A1 receptor. Besides many residues in the second and the third extracellular loops important for adenosine A1 receptor activation, we also identified two residues in EL2, a tryptophan and a glutamate, that affect the influence of the allosteric modulator PD81,723. These results, combined with a comparison of the different receptor loop regions, provide insight in the activation mechanism of this typical class A GPCR and further emphasize the unique pharmacological profile the loops can provide to individual receptors, even within subfamilies of GPCRs.

[1]  S. Dowell,et al.  A constitutively active G‐protein‐coupled receptor causes mating self‐compatibility in the mushroom Coprinus , 1999, The EMBO journal.

[2]  R. Paschke,et al.  Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. IJzerman,et al.  The structure of the adenosine receptors: implications for drug discovery. , 2011, Advances in pharmacology.

[4]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[5]  P. Conn,et al.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders. , 2010, Molecular bioSystems.

[6]  U. Holzgrabe,et al.  Allosteric Small Molecules Unveil a Role of an Extracellular E2/Transmembrane Helix 7 Junction for G Protein-coupled Receptor Activation* , 2007, Journal of Biological Chemistry.

[7]  R. Stevens,et al.  Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.

[8]  G. V. van Westen,et al.  Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. , 2011, Trends in pharmacological sciences.

[9]  G. V. van Westen,et al.  Three “hotspots” important for adenosine A2B receptor activation: a mutational analysis of transmembrane domains 4 and 5 and the second extracellular loop , 2011, Purinergic Signalling.

[10]  D. Scholl,et al.  Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor. , 2000, Biochemical pharmacology.

[11]  M. Marzioch,et al.  Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein α‐subunit chimeras , 2000, Yeast.

[12]  M. Wheatley,et al.  The third extracellular loop of G-protein-coupled receptors: more than just a linker between two important transmembrane helices. , 2004, Biochemical Society transactions.

[13]  P. Sexton,et al.  Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor , 2010, The Journal of Biological Chemistry.

[14]  Judy Lin,et al.  Hybrid ortho/allosteric ligands for the adenosine A(1) receptor. , 2010, Journal of medicinal chemistry.

[15]  Arthur Christopoulos,et al.  Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.

[16]  A. IJzerman,et al.  Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations. , 2004, Molecular pharmacology.

[17]  K. Jacobson,et al.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. , 1994, The Journal of biological chemistry.

[18]  P Corvol,et al.  Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Sexton,et al.  Determination of Adenosine A1 Receptor Agonist and Antagonist Pharmacology Using Saccharomyces cerevisiae: Implications for Ligand Screening and Functional Selectivity , 2009, Journal of Pharmacology and Experimental Therapeutics.

[20]  G. V. van Westen,et al.  GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  B. Kobilka,et al.  Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. , 2010, Physiology.

[22]  Ryan D. Morin,et al.  The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). , 2004, Genome research.

[23]  J. Klco,et al.  Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.

[24]  J. Klco,et al.  Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop* , 2006, Journal of Biological Chemistry.

[25]  R. Schiestl,et al.  Improved method for high efficiency transformation of intact yeast cells. , 1992, Nucleic acids research.

[26]  C. Langmead,et al.  Roof and Floor of the Muscarinic Binding Pocket: Variations in the Binding Modes of Orthosteric Ligands , 2007, Molecular Pharmacology.

[27]  J. Wess,et al.  Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition. , 1996, Molecular pharmacology.

[28]  M. Olah.  Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS , 1997, The Journal of Biological Chemistry.

[29]  B. Kieffer,et al.  The second extracellular loop: a damper for G protein–coupled receptors? , 2005, Nature Structural &Molecular Biology.

[30]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[31]  J. Wess,et al.  Multiple Residues in the Second Extracellular Loop Are Critical for M3 Muscarinic Acetylcholine Receptor Activation* , 2007, Journal of Biological Chemistry.

[32]  D. Higgins,et al.  T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.

[33]  A. Leslie,et al.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.

[34]  P. Sexton,et al.  Allosteric modulation of G protein-coupled receptors: A pharmacological perspective , 2011, Neuropharmacology.

[35]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[36]  Thomas Bäck,et al.  GPCR NaVa database: natural variants in human G protein‐coupled receptors , 2008, Human mutation.

[37]  P. Leff,et al.  The two-state model of receptor activation. , 1995, Trends in pharmacological sciences.

[38]  C. Lindsley,et al.  G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. , 2008, ACS chemical biology.

[39]  D. Filliol,et al.  Opioid receptor random mutagenesis reveals a mechanism for G protein–coupled receptor activation , 2003, Nature Structural Biology.

[40]  B. Fredholm,et al.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update , 2011, Pharmacological Reviews.

[41]  T. Nanevicz,et al.  Thrombin Receptor Activating Mutations , 1996, The Journal of Biological Chemistry.